Consequences of JAG1 mutations

被引:114
|
作者
Kamath, BM
Bason, L
Piccoli, DA
Krantz, ID
Spinner, NB
机构
[1] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Div Gastroenterol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Div Nutr, Philadelphia, PA 19104 USA
[4] DuPont Hosp, Div Genet, Delaware, DE USA
来源
JOURNAL OF MEDICAL GENETICS | 2003年 / 40卷 / 12期
关键词
D O I
10.1136/jmg.40.12.891
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Alagille syndrome (AGS) is a multi-system, autosomal dominant disorder with highly variable expressivity, caused by mutations within the Jagged1 (JAG1) gene. Methods: We studied 53 mutation positive relatives of 34 AGS probands to ascertain the frequency of clinical findings in JAG1 mutation carriers. Results: Eleven of 53 ( 21%) mutation positive relatives had clinical features that would have led to a diagnosis of AGS. Seventeen of the 53 (32%) relatives had mild features of AGS, revealed only after targeted evaluation following the diagnosis of a proband in their family. Twenty five of the 53 (47%) mutation positive relatives did not meet clinical criteria, and two of these individuals had no features consistent with AGS at all. The frequency of cardiac and liver disease was notably lower in the relatives than in the probands, characterising the milder end of the phenotypic spectrum. The characteristic facies of AGS was the feature with the highest penetrance, occuring almost universally in mutation positive probands and relatives. Conclusions: This study has implications for genetic counselling of families with AGS and JAG1 mutations.
引用
收藏
页码:891 / 895
页数:5
相关论文
共 50 条
  • [31] Pronounced vasculature phenotypes in new mouse models with ALGS and BA-associated mutations in Jag1
    Frontino, Anna Maria
    Oliveira, Daniel V.
    Trampotova, Eliska
    Tavakoli, Mitra
    Van Hul, Noemi K. M.
    Gozlan, Oren
    Andersson, Emma
    Pavlinkova, Gabriela
    Sprinzak, David
    Masek, Jan
    JOURNAL OF HEPATOLOGY, 2024, 80 : S697 - S698
  • [32] Parental mosaicism of JAG1 mutations in families with Alagille syndrome (vol 9, pg 209, 2001)
    Giannakudis, J
    Röpke, A
    Kujat, A
    Krajewska-Walasek, M
    Hughes, H
    Fryns, JP
    Bankier, A
    Amor, D
    Schlicker, M
    Hansmann, I
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2001, 9 (07) : 559 - 559
  • [33] Case Report: Novel JAG1 gene mutations in two infants with alagille syndrome characterized by cholestasis
    Han, Yijiang
    Zhu, Kun
    Wu, Hao
    Chen, Baohai
    Hu, Shuqi
    Lai, Dengming
    Tou, Jinfa
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [34] JAG1 is associated with the prognosis and metastasis in breast cancer
    Xiaojuan Qiao
    Buhuan Ma
    Weiting Sun
    Ning Zhang
    Yang Liu
    Lizhou Jia
    Caixia Liu
    Scientific Reports, 12
  • [35] Jagged1 (JAG1): Structure, expression, and disease associations
    Grochowski, Christopher M.
    Loomes, Kathleen M.
    Spinner, Nancy B.
    GENE, 2016, 576 (01) : 381 - 384
  • [36] JAG1 mediates apoptosis in herpes simplex keratitis by suppressing autophagy via ROS/JAG1/NOTCH1/pULK1 signaling pathway
    Chang, Jingyao
    Yao, Yao
    Sun, Xinghong
    Wang, Wenzhe
    Qian, Haochen
    Liu, Yumeilan
    Xue, Chunyan
    Ye, Wei
    Jiang, Feng
    CELL BIOLOGY AND TOXICOLOGY, 2024, 41 (01)
  • [37] A novel JAG1 mutation in a patient with Alagille's syndrome
    Wang, Ying
    Yu, Yongguo
    Wang, Jian
    Tsuei, Sian Hsiang-Te
    Zhao, Li
    Fu, Qihua
    PATHOLOGY, 2010, 42 (05) : 496 - 498
  • [38] Upregulated JAG1 Enhances Cell Proliferation in Adrenocortical Carcinoma
    Simon, Derek P.
    Giordano, Thomas J.
    Hammer, Gary D.
    CLINICAL CANCER RESEARCH, 2012, 18 (09) : 2452 - 2464
  • [39] Role of DLL4 and JAG1 in tumour angiogenesis
    Oon, C.
    Li, J.
    Sainson, R.
    Sheldon, H.
    Turley, H.
    Leek, R.
    Harris, A.
    EJC SUPPLEMENTS, 2010, 8 (05): : 92 - 92
  • [40] Could JAG1 protein inhibition prevent colorectal cancer?
    Lopez-Arribillaga, Erika
    Rodilla, Veronica
    Espinosa, Lluis
    FUTURE ONCOLOGY, 2019, 15 (04) : 345 - 347